Vion Pharmaceuticals Inc, Yale Universit deal

The parties amended the financial terms of two licensing agreements covering cancer and antiviral technologies licensed

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE